A tale of two drug targets: The evolutionary history of BACE1 and BACE2

Frontiers in Genetics

Volumn 4, Issue DEC, 2013, Pages

  Southan, Christopher ^a   Hancock, John M ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Alzheimer's Disease; BACE1; BACE2; Protein family evolution; Type II diabetes

Indexed keywords

EID: 84892376862     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00293     Document Type: Article

References (88)

1. Acquati, F., Accarino, M., Nucci, C., Fumagalli, P., Jovine, L., Ottolenghi, S., et al. (2000). The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett. 468, 59-64. doi: 10.1016/S0014-5793(00)01192-3.
2. Anwar, N., and Hunt, E. (2009). Improved data retrieval from TreeBASE via taxonomic and linguistic data enrichment. BMC Evol. Biol. 9:93. doi: 10.1186/1471-2148-9-93.
3. Arntfield, M. E., and van der Kooy, D. (2011). β-Cell evolution: How the pancreas borrowed from the brain: the shared toolbox of genes expressed by neural and pancreatic endocrine cells may reflect their evolutionary relationship. Bioessays 33, 582-587. doi: 10.1002/bies.201100015.
4. Attwood, T. K., Coletta, A., Muirhead, G., Pavlopoulou, A., Philippou, P. B., Popov, I., et al. (2012). The PRINTS database: a fine-grained protein sequence annotation and analysis resource-its status in 2012. Database 2012:bas019. doi: 10.1093/database/bas019.
5. Aufdem Keller, U., Doucet, A., and Overall, C. M. (2007). Protease research in the era of systems biology. Biol. Chem. 388, 1159-1162. doi: 10.1515/BC.2007.146.
6. Bastian, F., Parmentier, G., Roux, J., Moretti, S., Laudet, V., and Robinson-Rechavi, M. (2008). "Bgee: integrating and comparing heterogeneous transcriptome data among species," in Data Integration in the Life Sciences Lecture Notes in Computer Science, Vol. 5109, eds A. Bairoch, S. Cohen-Boulakia, and C. Froidevaux (Berlin: Springer), 124-131.
7. Blair, J. (2009). "Animals (Metazoa)," in The Timetree of Life, eds S. B. Hedges and S. Kumar (Oxford: Oxford University Press), 223-230.
8. Burkhardt, P., Stegmann, C. M., Cooper, B., Kloepper, T. H., Imig, C., Varoqueaux, F., et al. (2011). Primordial neurosecretory apparatus identified in the choanoflagellate Monosiga brevicollis. Proc. Natl. Acad. Sci. U.S.A. 108, 15264-15269. doi: 10.1073/pnas.1106189108.
9. Carmine-Simmen, K., Proctor, T., Tschäpe, J., Poeck, B., Triphan, T., Strauss, R., et al. (2009). Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function. Neurobiol. Dis. 33, 274-281. doi: 10.1016/j.nbd.2008.10.014.
10. Crooks, G. E., Hon, G., Chandonia, J.-M., and Brenner, S. E. (2004). WebLogo: a sequence logo generator. Genome Res. 14, 1188-1190. doi: 10.1101/gr.849004.
11. Dahlberg, C., Auger, H., Dupont, S., Sasakura, Y., Thorndyke, M., and Joly, J.-S. (2009). Refining the Ciona intestinalis model of central nervous system regeneration. PLoS ONE 4:e4458. doi: 10.1371/journal.pone.0004458.
12. Dislich, B., and Lichtenthaler, S. F. (2012). The membrane-bound aspartyl protease BACE1: molecular and functional properties in Alzheimer's disease and beyond. Front. Physiol. 3:8. doi: 10.3389/fphys.2012.00008.
13. Dominguez, D., Tournoy, J., Hartmann, D., Huth, T., Cryns, K., Deforce, S., et al. (2005). Phenotypic and biochemical analyses of BACE1-and BACE2-deficient mice. J. Biol. Chem. 280, 30797-30806. doi: 10.1074/jbc.M505249200.
14. Drew, B. T. (2013). Data deposition: missing data mean holes in tree of life. Nature 493, 305. doi: 10.1038/493305f.
15. Durham, T. B., and Shepherd, T. A. (2006). Progress toward the discovery and development of efficacious BACE inhibitors. Curr. Opin. Drug Discov. Devel. 9, 776-791.
16. Esterhazy, D., Stutzer, I., Wang, H., Rechsteiner, M. P., Beauchamp, J., Dobeli, H., et al. (2011). Bace2 is a beta cell-enriched protease that regulates pancreatic beta cell function and mass. Cell Metab. 14, 365-377. doi: 10.1016/j.cmet.2011.06.018.
17. Farzan, M., Schnitzler, C. E., Vasilieva, N., Leung, D., and Choe, H. (2000). BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc. Natl. Acad. Sci. U.S.A. 97, 9712-9717. doi: 10.1073/pnas.160115697.
18. Fleck, D., Garratt, A. N., Haass, C., and Willem, M. (2012). BACE1 dependent neuregulin proteolysis. Curr. Alzheimer Res. 9, 178-183. doi: 10.2174/156720512799361637.
19. Gascuel, O. (1997). BIONJ: an improved version of the NJ algorithm based on a simple model of sequence data. Mol. Biol. Evol. 14, 685-695. doi: 10.1093/oxfordjournals.molbev.a025808.
20. Goedert, M., and Spillantini, M. G. (2006). A century of Alzheimer's disease. Science 314, 777-781. doi: 10.1126/science.1132814.
21. Gonnet, G. H. (2012). Surprising results on phylogenetic tree building methods based on molecular sequences. BMC Bioinformatics 13:148. doi: 10.1186/1471-2105-13-148.
22. Hedges, S. B., Dudley, J., and Kumar, S. (2006). TimeTree: a public knowledge-base of divergence times among organisms. Bioinformatics 22, 2971-2972. doi: 10.1093/bioinformatics/btl505.
23. Hemming, M. L., Elias, J. E., Gygi, S. P., and Selkoe, D. J. (2009). Identification of beta-secretase (BACE1) substrates using quantitative proteomics. PLoS ONE 4:e8477. doi: 10.1371/journal.pone.0008477.
24. Henikoff, S., Henikoff, J. G., Alford, W. J., and Pietrokovski, S. (1995). Automated construction and graphical presentation of protein blocks from unaligned sequences. Gene 163, GC17-GC26. doi: 10.1016/0378-1119(95)00486-P.
25. Hilpert, H., Guba, W., Woltering, T. J., Wostl, W., Pinard, E., Mauser, H., et al. (2013). β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease. J. Med. Chem. 56, 3980-3995. doi: 10.1021/jm400225m.
26. Hogl, S., Kuhn, P. H., Colombo, A., and Lichtenthaler, S. F. (2011). Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and gamma-secretase. PLoS ONE 6:e21337. doi: 10.1371/journal.pone.0021337.
27. Hogl, S., van Bebber, F., Dislich, B., Kuhn, P.-H., Haass, C., Schmid, B., et al. (2013). Label-free quantitative analysis of the membrane proteome of Bace1 protease knock-out zebrafish brains. Proteomics 13, 1519-1527. doi: 10.1002/pmic.201200582.
28. Holland, P. W., Garcia-Fernandez, J., Williams, N. A., and Sidow, A. (1994). Gene duplications and the origins of vertebrate development. Dev. Suppl. Gene duplications and the origins of vertebrate development, 125-133.
29. Hufton, A. L., Groth, D., Vingron, M., Lehrach, H., Poustka, A. J., and Panopoulou, G. (2008). Early vertebrate whole genome duplications were predated by a period of intense genome rearrangement. Genome Res. 18, 1582-1591. doi: 10.1101/gr.080119.108.
30. Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., et al. (1999). Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14, 419-427. doi: 10.1006/mcne.1999.0811.
31. Hussain, I., Powell, D. J., Howlett, D. R., Chapman, G. A., Gilmour, L., Murdock, P. R., et al. (2000). ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site. Mol. Cell. Neurosci. 16, 609-619. doi: 10.1006/mcne.2000.0884.
32. Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., et al. (2012). A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 96-99. doi: 10.1038/nature11283.
33. Karran, E., Mercken, M., and De Strooper, B. (2011). The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 10, 698-712. doi: 10.1038/nrd3505.
34. King, N., Westbrook, M. J., Young, S. L., Kuo, A., Abedin, M., Chapman, J., et al. (2008). The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans. Nature 451, 783-788. doi: 10.1038/nature06617.
35. Kosakovsky Pond, S. L., and Frost, S. D. W. (2005). Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 22, 1208-1222. doi: 10.1093/molbev/msi105.
36. Kovacs, D. M., Gersbacher, M. T., and Kim, D. Y. (2010). Alzheimer's secretases regulate voltage-gated sodium channels. Neurosci. Lett. 486, 68-72. doi: 10.1016/j.neulet.2010.08.048.
37. Kuhn, P.-H., Koroniak, K., Hogl, S., Colombo, A., Zeitschel, U., Willem, M., et al. (2012). Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J. 31, 3157-3168. doi: 10.1038/emboj.2012.173.
38. Kuraku, S., Meyer, A., and Kuratani, S. (2009). Timing of genome duplications relative to the origin of the vertebrates: did cyclostomes diverge before or after? Mol. Biol. Evol. 26, 47-59. doi: 10.1093/molbev/msn222.
39. Lal, M., and Caplan, M. (2011). Regulated intramembrane proteolysis: signaling pathways and biological functions. Physiology 26, 34-44. doi: 10.1152/physiol.00028.2010.
40. Laskowski, R. A. (2009). PDBsum new things. Nucleic Acids Res. 37, D355-D359. doi: 10.1093/nar/gkn860.
41. Leebens-Mack, J., Vision, T., Brenner, E., Bowers, J. E., Cannon, S., Clement, M. J., et al. (2006). Taking the first steps towards a standard for reporting on phylogenies: Minimum Information About a Phylogenetic Analysis (MIAPA). Omics 10, 231-237. doi: 10.1089/omi.2006.10.231.
42. Lichtenthaler, S. F., Haass, C., and Steiner, H. (2011). Regulated intramembrane proteolysis-lessons from amyloid precursor protein processing. J. Neurochem. 117, 779-796. doi: 10.1111/j.1471-4159.2011.07248.x.
43. Liebeskind, B. J., Hillis, D. M., and Zakon, H. H. (2011). Evolution of sodium channels predates the origin of nervous systems in animals. Proc. Natl. Acad. Sci. U.S.A. 108, 9154-9159. doi: 10.1073/pnas.1106363108.
44. Löytynoja, A., and Goldman, N. (2010). webPRANK: a phylogeny-aware multiple sequence aligner with interactive alignment browser. BMC Bioinformatics 11:579. doi: 10.1186/1471-2105-11-579.
45. Lynch, M., and Conery, J. S. (2000). The evolutionary fate and consequences of duplicate genes. Science 290, 1151-1155. doi: 10.1126/science.290.5494.1151.
46. Lynch, M., and Force, A. (2000). The probability of duplicate gene preservation by subfunctionalization. Genetics 154, 459-473.
47. Lynch, M., O'Hely, M., Walsh, B., and Force, A. (2001). The probability of preservation of a newly arisen gene duplicate. Genetics 159, 1789-1804.
48. Ma, H., Lesne, S., Kotilinek, L., Steidl-Nichols, J. V., Sherman, M., Younkin, L., et al. (2007). Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity. Proc. Natl. Acad. Sci. U.S.A. 104, 8167-8172. doi: 10.1073/pnas.0609521104.
49. May, P. C., Dean, R. A., Lowe, S. L., Martenyi, F., Sheehan, S. M., Boggs, L. N., et al. (2011). Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor. J. Neurosci. 31, 16507-16516. doi: 10.1523/JNEUROSCI.3647-11.2011.
50. Miyata, T., and Suga, H. (2001). Divergence pattern of animal gene families and relationship with the Cambrian explosion. Bioessays 23, 1018-1027. doi: 10.1002/bies.1147.
51. Morin, R. D., Chang, E., Petrescu, A., Liao, N., Griffith, M., Chow, W., et al. (2006). Sequencing and analysis of 10,967 full-length cDNA clones from Xenopus laevis and Xenopus tropicalis reveals post-tetraploidization transcriptome remodeling. Genome Res. 16, 796-803. doi: 10.1101/gr.4871006.
52. Olson, R. E., and Albright, C. F. (2008). Recent progress in the medicinal chemistry of gamma-secretase inhibitors. Curr. Top. Med. Chem. 8, 17-33. doi: 10.2174/156802608783334088.
53. Osigus, H.-J., Eitel, M., and Schierwater, B. (2013). Chasing the urmetazoon: striking a blow for quality data? Mol. Phylogenet. Evol. 66, 551-557. doi: 10.1016/j.ympev.2012.05.028.
54. Papadopoulos, J. S., and Agarwala, R. (2007). COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics 23, 1073-1079. doi: 10.1093/bioinformatics/btm076.
55. Pieler, T., and Chen, Y. (2006). Forgotten and novel aspects in pancreas development. Biol. Cell 98, 79-88. doi: 10.1042/BC20050069.
56. Probst, G., and Xu, Y. (2012). Small-molecule BACE1 inhibitors: a patent literature review (2006-2011). Expert Opin. Ther. Pat. 22, 511-540. doi: 10.1517/13543776.2012.681302.
57. Pruitt, K. D., Harrow, J., Harte, R. A., Wallin, C., Diekhans, M., Maglott, D. R., et al. (2009). The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes. Genome Res. 19, 1316-1323. doi: 10.1101/gr.080531.108.
58. Quigley, I. K., Turner, J. M., Nuckels, R. J., Manuel, J. L., Budi, E. H., MacDonald, E. L., et al. (2004). Pigment pattern evolution by differential deployment of neural crest and post-embryonic melanophore lineages in Danio fishes. Development 131, 6053-6069. doi: 10.1242/dev.01526.
59. Rausch, T., Emde, A.-K., Weese, D., Döring, A., Notredame, C., and Reinert, K. (2008). Segment-based multiple sequence alignment. Bioinformatics 24, i187-i192. doi: 10.1093/bioinformatics/btn281.
60. Rawlings, N. D., and Bateman, A. (2009). Pepsin homologues in bacteria. BMC Genomics 10:437. doi: 10.1186/1471-2164-10-437.
61. Rawlings, N. D., Morton, F. R., Kok, C. Y., Kong, J., and Barrett, A. J. (2008). MEROPS: the peptidase database. Nucleic Acids Res. 36, D320-D325. doi: 10.1093/nar/gkm954.
62. Rochin, L., Hurbain, I., Serneels, L., Fort, C., Watt, B., Leblanc, P., et al. (2013). BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells. Proc. Natl. Acad. Sci. U.S.A. 110, 10658-10663. doi: 10.1073/pnas.1220748110.
63. Ruan, J., Li, H., Chen, Z., Coghlan, A., Coin, L. J. M., Guo, Y., et al. (2008). TreeFam: 2008 Update. Nucleic Acids Res. 36, D735-D740. doi: 10.1093/nar/gkm1005.
64. Schechter, I., and Ziv, E. (2011). Cathepsins, S., B and L with aminopeptidases display β-secretase activity associated with the pathogenesis of Alzheimer's disease. Biol. Chem. 392, 555-569. doi: 10.1515/bc.2011.054.
65. Selkoe, D. J., and Wolfe, M. S. (2007). Presenilin: running with scissors in the membrane. Cell 131, 215-221. doi: 10.1016/j.cell.2007.10.012.
66. Shaffer, H. B., Minx, P., Warren, D. E., Shedlock, A. M., Thomson, R. C., Valenzuela, N., et al. (2013). The western painted turtle genome, a model for the evolution of extreme physiological adaptations in a slowly evolving lineage. Genome Biol. 14:R28. doi: 10.1186/gb-2013-14-3-r28.
67. Singh, J. (2011). FigShare. J. Pharmacol. Pharmacother. 2, 138-139. doi: 10.4103/0976-500X.81919.
68. Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., et al. (1999). Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537-540. doi: 10.1038/990114.
69. Southan, C. (2007). Exploiting new genome data and Internet resources for the phylogenetic analysis of proteases, substrates and inhibitors. Biochem. Soc. Trans. 35, 599-603. doi: 10.1042/BST0350599.
70. Southan, C. (2013). BACE2 as a new diabetes target: a patent review (2010-2012). Expert Opin. Ther. Pat. 23, 649-663. doi: 10.1517/13543776.2013.780032.
71. Southan, C., Boppana, K., Jagarlapudi, S. A., and Muresan, S. (2011). Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: ranking 1654 human protein targets by assayed compounds and molecular scaffolds. J. Cheminform. 3, 14. doi: 10.1186/1758-2946-3-14.
72. Srivastava, M., Begovic, E., Chapman, J., Putnam, N. H., Hellsten, U., Kawashima, T., et al. (2008). The Trichoplax genome and the nature of placozoans. Nature 454, 955-960. doi: 10.1038/nature07191.
73. Stamford, A. W., Scott, J. D., Li, S. W., Babu, S., Tadesse, D., Hunter, R., et al. (2012). Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS Aβ Reduction. ACS Med. Chem. Lett. 3, 897-902. doi: 10.1021/ml3001165.
74. Stockley, J. H., and O'Neill, C. (2008). Understanding BACE1: essential protease for amyloid-beta production in Alzheimer's disease. Cell. Mol. Life Sci. 65, 3265-3289. doi: 10.1007/s00018-008-8271-3.
75. Stoltzfus, A., O'Meara, B., Whitacre, J., Mounce, R., Gillespie, E. L., Kumar, S., et al. (2012). Sharing and re-use of phylogenetic trees (and associated data) to facilitate synthesis. BMC Res. Notes 5:574. doi: 10.1186/1756-0500-5-574.
76. Stützer, I., Selevsek, N., Esterházy, D., Schmidt, A., Aebersold, R., and Stoffel, M. (2013). Systematic proteomic analysis identifies β-site amyloid precursor protein cleaving enzyme 2 and 1 (BACE2 and BACE1) substrates in pancreatic β-cells. J. Biol. Chem. 288, 10536-10547. doi: 10.1074/jbc.M112.444703.
77. Sun, X., He, G., and Song, W. (2006). BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J. 20, 1369-1376. doi: 10.1096/fj.05-5632com.
78. Sun, X., Wang, Y., Qing, H., Christensen, M. A., Liu, Y., Zhou, W., et al. (2005). Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes. FASEB J. 19, 739-749. doi: 10.1096/fj.04-3426com.
79. Toyn, J. H., Lin, X.-A., Thompson, M. W., Guss, V., Meredith, J. E., Sankaranarayanan, S., et al. (2010). Viable mouse gene ablations that robustly alter brain Aβ levels are rare. BMC Neurosci. 11:143. doi: 10.1186/1471-2202-11-143.
80. Van Bebber, F., Hruscha, A., Willem, M., Schmid, B., and Haass, C. (2013). Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes. J. Neurochem. 127, 471-481. doi: 10.1111/jnc.12198.
81. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., et al. (1999). Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741. doi: 10.1126/science.286.5440.735.
82. Venkatesh, B., Kirkness, E. F., Loh, Y. H., Halpern, A. L., Lee, A. P., Johnson, J., et al. (2007). Survey sequencing and comparative analysis of the elephant shark (Callorhinchus milii) genome. PLoS Biol. 5:e101. doi: 10.1371/journal.pbio.0050101.
83. Venugopal, C., Demos, C. M., Rao, K. S., Pappolla, M. A., and Sambamurti, K. (2008). Beta-secretase: structure, function, and evolution. CNS Neurol. Disord. Drug Targets 7, 278-294. doi: 10.2174/187152708784936626.
84. Vetrivel, K. S., Meckler, X., Chen, Y., Nguyen, P. D., Seidah, N. G., Vassar, R., et al. (2009). Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. J. Biol. Chem. 284, 3793-3803. doi: 10.1074/jbc.M808920200.
85. Weiss, M. M., Williamson, T., Babu-Khan, S., Bartberger, M. D., Brown, J., Chen, K., et al. (2012). Design and preparation of a potent series of hydroxyethylamine containing β-secretase inhibitors that demonstrate robust reduction of central β-amyloid. J. Med. Chem. 55, 9009-9024. doi: 10.1021/jm300119p.
86. Xia, W., Wong, S. T., Hanlon, E., and Morin, P. (2012). γ-Secretase modulator in Alzheimer's disease: shifting the end. J. Alzheimer's Dis. 31, 685-696. doi: 10.3233/Jad-2012-120751.
87. Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., et al. (1999). Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537. doi: 10.1038/990107.
88. Zakon, H. H. (2012). Adaptive evolution of voltage-gated sodium channels: the first 800 million years. Proc. Natl. Acad. Sci. U.S.A. 109(Suppl.), 10619-10625. doi: 10.1073/pnas.1201884109.